北京协和制药二厂

Beijing Union Pharmaceutical Factory No. 2 is a specialized pharmaceutical manufacturing enterprise affiliated with the Institute of Materia Medica (IMM) of the Chinese Academy of Medical Sciences (CAMS). Located in Beijing's Daxing District, the facility serves as the primary industrialization base for innovative drugs developed by the IMM. The company is most notably recognized for the production of Bicyclol, a first-in-class anti-hepatitis drug developed in China. Its operations encompass the manufacturing of chemical synthetic drugs, modernized traditional Chinese medicine extracts, and various oral solid dosage forms under strict GMP standards. The factory plays a pivotal role in bridging the gap between academic drug discovery and large-scale commercial supply within the Chinese healthcare market.